| Rehabilitation Post Lumbar Microdiscectomy (NCT00306423) | University of Southern California | 2003-06-01 |
| VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies (NCT00070538) | Vion Pharmaceuticals | 2003-06-01 |
| Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children (NCT00317473) | U.S. Army Medical Research and Development Command | 2003-06-01 |
| Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF) (NCT00095706) | Translational Oncology Research International | 2003-06-01 |
| Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer (NCT01016639) | Lund University Hospital | 2003-06-01 |
| Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1 (NCT00067535) | National Institute on Drug Abuse (NIDA) | 2003-06-01 |
| Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma (NCT00062036) | National Institutes of Health Clinical Center (CC) | 2003-06-01 |
| Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer (NCT00114153) | University of Virginia | 2003-06-01 |
| A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or Placebo (NCT00158093) | Mylan Bertek Pharmaceuticals | 2003-06-01 |
| Pharmacokinetics and Pharmacodynamics of BIWH 3 in Healthy Duffy Positive vs. Duffy Negative Male Volunteers (NCT02249117) | Boehringer Ingelheim | 2003-06-01 |
| A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fed Conditions (NCT00864890) | Actavis Inc. | 2003-06-01 |
| Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer (NCT00239304) | AstraZeneca | 2003-06-01 |
| A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations (NCT00796471) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-06-01 |
| Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer (NCT00073866) | Northwestern University | 2003-06-01 |
| Effect of Folate on Colon and Blood Cells (NCT00220012) | Rockefeller University | 2003-06-01 |
| Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal Neoplasia (NCT00611000) | Rockefeller University | 2003-06-01 |
| Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer (NCT00264134) | Kentuckiana Cancer Institute | 2003-06-01 |
| Rituximab in the Treatment of Graves' Disease (NCT00150111) | Odense University Hospital | 2003-06-01 |
| Wild Type p53 Adenovirus for Oral Premalignancies (NCT00410865) | M.D. Anderson Cancer Center | 2003-06-01 |
| Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes (NCT00063583) | Sharma, Kumar, M.D. | 2003-06-01 |
| Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2) (NCT00188578) | University Health Network, Toronto | 2003-06-01 |
| Hypertonic Saline Use in Preeclampsia (NCT00181077) | Johns Hopkins University | 2003-06-01 |
| A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy (NCT00328432) | University of Kansas | 2003-06-01 |
| A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children (NCT00174473) | Pfizer | 2003-06-01 |
| Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers (NCT00122564) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-06-01 |
| Bioavailability Study of Leflunomide Tablets Under Fasting Conditions (NCT00652665) | Par Pharmaceutical, Inc. | 2003-06-01 |
| Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM) (NCT00073255) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-06-01 |
| Fasting Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg (NCT00648921) | Mylan Pharmaceuticals Inc | 2003-06-01 |
| Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs (NCT00062816) | Ionis Pharmaceuticals, Inc. | 2003-06-01 |
| Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment (NCT00061347) | National Cancer Institute (NCI) | 2003-05-23 |
| Sequential Vaccinations in Prostate Cancer Patients (NCT00060528) | National Cancer Institute (NCI) | 2003-05-22 |
| Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer (NCT00064129) | National Cancer Institute (NCI) | 2003-05-13 |
| Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy (NCT00060749) | National Eye Institute (NEI) | 2003-05-05 |
| Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer's Disease (NCT00100282) | PRAECIS Pharmaceuticals Inc. | 2003-05-01 |
| Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia (NCT00062244) | National Cancer Institute (NCI) | 2003-05-01 |
| Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg (NCT00648349) | Mylan Pharmaceuticals Inc | 2003-05-01 |
| A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG (NCT00427830) | University of Oxford | 2003-05-01 |
| Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant (NCT00068718) | Fred Hutchinson Cancer Center | 2003-05-01 |
| Phase I Safety Study of DMXAA in Refractory Tumors (NCT00856336) | Antisoma Research | 2003-05-01 |
| Cognitive and Health Benefits of Expressive Writing for Family Caregivers Under Stress (NCT00303147) | University of Toronto | 2003-05-01 |
| Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions (NCT00233714) | Cordis US Corp. | 2003-05-01 |
| Endothelin-Receptor Blockade in Coronary Heart Disease (NCT00427232) | Medical University of Vienna | 2003-05-01 |
| Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer (NCT00063947) | National Cancer Institute (NCI) | 2003-05-01 |
| Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer (NCT00062907) | Corixa Corporation | 2003-05-01 |
| Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer (NCT00062270) | University of Alabama at Birmingham | 2003-05-01 |
| Isolated Liver Perfusion With Oxaliplatin (NCT01042691) | David Bartlett | 2003-05-01 |
| Pneumococcal Adult-dose Ranging Immunization Study (NCT00169234) | Kaiser Permanente | 2003-05-01 |
| Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED) (NCT00060645) | Merck Sharp & Dohme LLC | 2003-05-01 |
| Single Rising Dose Study Investigating the Safety, Tolerability and Pharmacokinetics of Spray Dried BIBN 4096 BS After Inhalation Administration in Healthy Male and Female Volunteers (NCT02199860) | Boehringer Ingelheim | 2003-05-01 |
| Effect of a Fatty Meal on Endoscopic Retrograde Cholangiopancreatography (ERCP) (NCT00124202) | Emory University | 2003-05-01 |
| Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer (NCT00063934) | National Cancer Institute (NCI) | 2003-05-01 |
| Pharmacokinetics of Naltrexone Following Intravenous and Oral Routes of Administration in Healthy Volunteers (NCT00714584) | Alza Corporation, DE, USA | 2003-05-01 |
| -Methylenedioxymethamphetamine (MDMA, Ecstasy) Induced Changes in Drug Metabolism: Gender and Genetic Polymorphisms (NCT01447472) | Parc de Salut Mar | 2003-05-01 |
| Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mg (NCT00649493) | Mylan Pharmaceuticals Inc | 2003-05-01 |
| Muscle Perfusion and Protein Metabolism in Elderly (NCT00945256) | The University of Texas Medical Branch, Galveston | 2003-05-01 |
| Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer (NCT00093652) | Roswell Park Cancer Institute | 2003-05-01 |
| Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma (NCT00317759) | Fred Hutchinson Cancer Center | 2003-05-01 |
| Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP) (NCT01713738) | Neufeld, Ellis J, MD, PhD | 2003-05-01 |
| Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy (NCT00066547) | Jonsson Comprehensive Cancer Center | 2003-05-01 |
| Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers (NCT01848002) | Novo Nordisk A/S | 2003-05-01 |
| A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis (NCT00382512) | Genentech, Inc. | 2003-05-01 |
| NK-1 Antagonism of SLV317 in Humans (NCT00160862) | Heidelberg University | 2003-05-01 |
| Long-term Nutritional Intervention Study to Determine How Protein Affects Calcium Metabolism (NCT00671944) | Yale University | 2003-05-01 |
| Raman Scattering Spectroscopy to Measure Macular Pigment (NCT00060580) | National Eye Institute (NEI) | 2003-05-01 |
| Comparison of Two Psychotherapy Treatments for Depressed Women With a History of Sexual Abuse (NCT00257400) | University of Rochester | 2003-05-01 |
| Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μg (NCT00647855) | Mylan Pharmaceuticals Inc | 2003-05-01 |
| Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor (NCT00095329) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-05-01 |
| Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma (NCT00230386) | University Health Network, Toronto | 2003-05-01 |
| Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies (NCT00943293) | University of Chicago | 2003-05-01 |
| Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers (NCT00061997) | British Columbia Cancer Agency | 2003-05-01 |
| Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration (NCT01570790) | Johns Hopkins University | 2003-05-01 |
| Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors (NCT00186979) | St. Jude Children's Research Hospital | 2003-05-01 |
| Phase I Study of Sequential Cord Blood Transplants (NCT00299767) | Massachusetts General Hospital | 2003-05-01 |
| Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg (NCT00647972) | Mylan Pharmaceuticals Inc | 2003-05-01 |
| Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors (NCT00193583) | SCRI Development Innovations, LLC | 2003-05-01 |
| A Study of Safety, Tolerability and Immunogenicity of a 1-Dose Regimen of MRKAd5 HIV-1 Gag Vaccine Versus the ALVAC_HIV Vaccine (V520-019) (NCT00894114) | Merck Sharp & Dohme LLC | 2003-05-01 |
| Mesalamine 4 gm/60 mL Rectal Enema (NCT00840203) | Teva Pharmaceuticals USA | 2003-05-01 |
| Safety, Tolerability and Pharmacokinetics of KUC 7483 Tablets in Healthy Male Volunteers (NCT02259907) | Boehringer Ingelheim | 2003-05-01 |
| A Study of the Bioequivalence of 70 mg Alendronate and 70 mg Alendronate in Combination With 2800 IU Vitamin D (NCT00806416) | Organon and Co | 2003-05-01 |
| Effects Of GW572016 In Combination With Docetaxel (TAXOTERE) (NCT00148902) | GlaxoSmithKline | 2003-04-28 |
| A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV) (NCT03407105) | Bristol-Myers Squibb | 2003-04-21 |
| OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors (NCT00471432) | NCIC Clinical Trials Group | 2003-04-04 |
| An Dose Escalation Study of BIBF 1120 Administered in Patients With Relapsed or Refractory Multiple Myeloma (NCT02182141) | Boehringer Ingelheim | 2003-04-01 |
| Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer (NCT00280176) | UNC Lineberger Comprehensive Cancer Center | 2003-04-01 |
| Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00062140) | Fred Hutchinson Cancer Center | 2003-04-01 |
| Dose-Response Study of Probiotic Bacteria BB-12 and CRL-431 in Healthy Young Adults (NCT00611299) | University of Copenhagen | 2003-04-01 |
| Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer (NCT00060359) | Gynecologic Oncology Group | 2003-04-01 |
| Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer (NCT00070057) | National Cancer Institute (NCI) | 2003-04-01 |
| Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00049218) | H. Lee Moffitt Cancer Center and Research Institute | 2003-04-01 |
| BCX-1777 in Treating Patients With Refractory Cancer (NCT00073944) | BioCryst Pharmaceuticals | 2003-04-01 |
| MRI Superficial Temporal Artery (NCT00188448) | University Health Network, Toronto | 2003-04-01 |
| Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma (NCT00061035) | Cosmo Bioscience | 2003-04-01 |
| A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016) (NCT00849680) | Merck Sharp & Dohme LLC | 2003-04-01 |
| Emergency Linkage to Outpatient Psychiatric Services (NCT00278811) | University of Rochester | 2003-04-01 |
| Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients (NCT00085930) | Baylor College of Medicine | 2003-04-01 |
| Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma (NCT00058240) | National Cancer Institute (NCI) | 2003-04-01 |
| Amlodipine 10 mg Tablets Under Fed Conditions (NCT00841815) | Teva Pharmaceuticals USA | 2003-04-01 |
| Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan (NCT00249977) | University of New Mexico | 2003-04-01 |
| A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults (NCT00057525) | DynPort Vaccine Company LLC, A GDIT Company | 2003-04-01 |
| Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia (NCT00060294) | Jonsson Comprehensive Cancer Center | 2003-04-01 |